Related references
Note: Only part of the references are listed.Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets
Evan Rosenbaum et al.
MODERN PATHOLOGY (2020)
YAP1-fusions in pediatric NF2-wildtype meningioma
Philipp Sievers et al.
ACTA NEUROPATHOLOGICA (2020)
Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma
Yu-Chien Kao et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
YAP1/TAZ drives ependymoma-like tumour formation in mice
Noreen Eder et al.
NATURE COMMUNICATIONS (2020)
Measuring Real-time Drug Response in Organotypic Tumor Tissue Slices
Nao Nishida-Aoki et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2020)
Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening
Gabriele Picco et al.
NATURE COMMUNICATIONS (2019)
Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma
Shigeki Sekine et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
Kristian W. Pajtler et al.
NATURE COMMUNICATIONS (2019)
Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery
Ramya Sivakumar et al.
ONCOIMMUNOLOGY (2019)
TumorFusions: an integrative resource for cancer-associated transcript fusions
Xin Hu et al.
NUCLEIC ACIDS RESEARCH (2018)
Somatic genome editing with the RCAS-TVA-CRISPR-Cas9 system for precision tumor modeling
Barbara Oldrini et al.
NATURE COMMUNICATIONS (2018)
A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-kappa B
Tatsuya Ozawa et al.
CELL REPORTS (2018)
The Ambivalent Function of YAP in Apoptosis and Cancer
Xianbin Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Automated in situ chromatin profiling efficiently resolves cell types and gene regulatory programs
Derek H. Janssens et al.
EPIGENETICS & CHROMATIN (2018)
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer
Yumeng Wang et al.
CELL REPORTS (2018)
Regulation of Hippo pathway transcription factor TEAD by p38 MAPK-induced cytoplasmic translocation
Kimberly C. Lin et al.
NATURE CELL BIOLOGY (2017)
Role of Merlin/NF2 inactivation in tumor biology
A. M. Petrilli et al.
ONCOGENE (2016)
Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein
M. R. Tanas et al.
ONCOGENE (2016)
Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups
Kristian W. Pajtler et al.
CANCER CELL (2015)
YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers
Giorgio G. Galli et al.
MOLECULAR CELL (2015)
Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway
Jung-Soo Mo et al.
NATURE CELL BIOLOGY (2015)
YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
Claudia Stein et al.
PLOS GENETICS (2015)
A review: molecular aberrations within Hippo signaling in bone and soft-tissue sarcomas
Michael D. Deel et al.
FRONTIERS IN ONCOLOGY (2015)
Most Human Non-GCIMP Glioblastoma Subtypes Evolve from a Common Proneural-like Precursor Glioma
Tatsuya Ozawa et al.
CANCER CELL (2014)
The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
Katarzyna Brodowska et al.
EXPERIMENTAL EYE RESEARCH (2014)
NTRK1 Fusion in Glioblastoma Multiforme
Jinkuk Kim et al.
PLOS ONE (2014)
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma
Cristina R. Antonescu et al.
GENES CHROMOSOMES & CANCER (2013)
Fusion genes in solid tumors: an emerging target for cancer diagnosis and treatment
Brittany C. Parker et al.
CHINESE JOURNAL OF CANCER (2013)
Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
Yi Liu-Chittenden et al.
GENES & DEVELOPMENT (2012)
LATS tumor suppressor A new governor of cellular homeostasis
Stacy Visser et al.
CELL CYCLE (2010)
Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains
Nicolas Reynoird et al.
EMBO JOURNAL (2010)
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF beta-TRCP
Bin Zhao et al.
GENES & DEVELOPMENT (2010)
TEAD mediates YAP-dependent gene induction and growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2008)
Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence
Maki Fukami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
Dissecting nuclear Wingless signalling:: Recruitment of the transcriptional co-activator Pygopus by a chain of adaptor proteins
R Städeli et al.
MECHANISMS OF DEVELOPMENT (2005)
Renal carcinoma-associated transcription factors TFE3 and TFEB are leukemia inhibitory factor-responsive transcription activators of E-cadherin
CM Huan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Identification of new human mastermind proteins defines a family that consists of positive regulators for notch signaling
SE Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Leukemia proto-oncoprotein MLL is proteolytically processed into 2 fragments with opposite transcriptional properties
A Yokoyama et al.
BLOOD (2002)
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
AB Dash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice
EC Holland et al.
NATURE GENETICS (2000)
Share Paper
